Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women¶
Writing Group for the Women's Health Initiative Investigators. (2002). Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial. JAMA, 288(3), 321-333.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Primes¶
- Confounding
- The Women's Health Initiative (WHI) hormone-replacement-therapy (HRT) randomized trial, reporting its initial results in 2002 (Rossouw et al. JAMA), provides a canonical demonstration of confounding in observational research and its resolution through experimentation
This sourceThe WHI RCT that was stopped early for unfavorable risk–benefit (CHD hazard ratio ≈1.29); the canonical observational-to-experimental reversal demonstrating confounding (supports D25-025).
- The Women's Health Initiative (WHI) hormone-replacement-therapy (HRT) randomized trial, reporting its initial results in 2002 (Rossouw et al. JAMA), provides a canonical demonstration of confounding in observational research and its resolution through experimentation
Verification¶
This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.
Registry ID ref:40cda9310357 · see in the full table